Inherited human ZNF341 deficiency
暂无分享,去创建一个
A. Puel | V. Béziat | C. Fieschi | M. Migaud | R. Djidjik | B. Belaid | Mana Momenilandi | M. Momenilandi
[1] R. Sherkat,et al. Ciliary and immune dysfunctions and their genetic background in patients with non-cystic fibrosis bronchiectasis in Central Iran , 2022, Irish Journal of Medical Science (1971 -).
[2] B. Garty,et al. Hyper IgE Syndrome in an Isolated Population in Israel , 2022, Frontiers in Immunology.
[3] Xiaoying Hu,et al. The JAK/STAT signaling pathway: from bench to clinic , 2021, Signal Transduction and Targeted Therapy.
[4] J. Casanova,et al. Genetic, Immunological, and Clinical Features of 32 Patients with Autosomal Recessive STAT1 Deficiency , 2021, The Journal of Immunology.
[5] J. Casanova,et al. Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance , 2021, The Journal of experimental medicine.
[6] A. Gennery,et al. STAT3 Hyper-IgE Syndrome—an Update and Unanswered Questions , 2021, Journal of Clinical Immunology.
[7] R. Uppuluri,et al. Clinical Profile of Hyper-IgE Syndrome in India , 2021, Frontiers in Immunology.
[8] J. Casanova,et al. Negative selection on human genes underlying inborn errors depends on disease outcome and both the mode and mechanism of inheritance , 2021, Proceedings of the National Academy of Sciences.
[9] Jinqiao Sun,et al. The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations , 2020, Allergy, Asthma & Clinical Immunology.
[10] Liping Jiang,et al. Autosomal dominant hyper IgE syndrome from a single centre in Chongqing, China (2009‐2018) , 2020, Scandinavian journal of immunology.
[11] David R. Murdock,et al. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome , 2020, The Journal of experimental medicine.
[12] A. Puel. Human inborn errors of immunity underlying superficial or invasive candidiasis , 2020, Human Genetics.
[13] J. Casanova,et al. Efficacy of Dupilumab for Controlling Severe Atopic Dermatitis in a Patient with Hyper-IgE Syndrome , 2020, Journal of Clinical Immunology.
[14] D. Gisselsson,et al. Absence of GP130 cytokine receptor signaling causes extended Stüve-Wiedemann syndrome , 2020, The Journal of experimental medicine.
[15] Ryan L. Collins,et al. The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.
[16] L. Dotta,et al. Autosomal-dominant hyper-IgE syndrome is associated with appearance of infections early in life and/or neonatal rash: Evidence from the Italian cohort of 61 patients with elevated IgE. , 2019, The journal of allergy and clinical immunology. In practice.
[17] Kenneth G. C. Smith,et al. Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses , 2019, The Journal of experimental medicine.
[18] N. Rezaei,et al. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long‐term follow‐up and genetic analysis , 2019, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[19] I. Tezcan,et al. Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function , 2018, Haematologica.
[20] J. Casanova,et al. Human hyper-IgE syndrome: singular or plural? , 2018, Mammalian Genome.
[21] D. Chaussabel,et al. A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity , 2018, Science Immunology.
[22] A. Schäffer,et al. ZNF341 controls STAT3 expression and thereby immunocompetence , 2018, Science Immunology.
[23] S. Holland,et al. A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis , 2017, The Journal of experimental medicine.
[24] S. Holland,et al. Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome , 2017, Journal of Clinical Immunology.
[25] Tong-Xin Chen,et al. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review , 2017, Journal of Clinical Immunology.
[26] J. Casanova,et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency , 2016, Proceedings of the National Academy of Sciences.
[27] Andrew Emili,et al. Multiparameter functional diversity of human C2H2 zinc finger proteins , 2016, Genome research.
[28] C. Cunningham-Rundles,et al. Hemoptysis in a Patient with Elevated Immunoglobulin E. , 2016, The journal of allergy and clinical immunology. In practice.
[29] Lluis Quintana-Murci,et al. The mutation significance cutoff: gene-level thresholds for variant predictions , 2016, Nature Methods.
[30] J. Casanova,et al. STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and function , 2015, The Journal of experimental medicine.
[31] O. Sanal,et al. Combined immunodeficiency with CD4 lymphopenia and sclerosing cholangitis caused by a novel loss-of-function mutation affecting IL21R , 2015, Haematologica.
[32] Anna Lindstrand,et al. Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features. , 2015, American journal of human genetics.
[33] Joshua L. Deignan,et al. De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay. , 2015, American journal of human genetics.
[34] M. Seidl,et al. Extending the clinical and immunological phenotype of human interleukin-21 receptor deficiency , 2015, Haematologica.
[35] J. Colinge,et al. Early-onset inflammatory bowel disease and common variable immunodeficiency-like disease caused by IL-21 deficiency. , 2014, The Journal of allergy and clinical immunology.
[36] R. Carpenter,et al. STAT1 gene expression is enhanced by nuclear EGFR and HER2 via cooperation With STAT3 , 2013, Molecular carcinogenesis.
[37] A. Hoischen,et al. Mutations in the interleukin receptor IL11RA cause autosomal recessive Crouzon-like craniosynostosis , 2013, Molecular genetics & genomic medicine.
[38] J. Casanova,et al. Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function. , 2013, The Journal of allergy and clinical immunology.
[39] A. Schäffer,et al. Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome , 2013, The Journal of experimental medicine.
[40] J. Casanova,et al. Dominant‐negative STAT1 SH2 domain mutations in unrelated patients with mendelian susceptibility to mycobacterial disease , 2012, Human mutation.
[41] A. Fischer,et al. Autosomal Dominant STAT3 Deficiency and Hyper-IgE Syndrome: Molecular, Cellular, and Clinical Features From a French National Survey , 2012, Medicine.
[42] Zuoming Sun,et al. Protein Kinase C-θ Promotes Th17 Differentiation via Upregulation of Stat3 , 2012, The Journal of Immunology.
[43] J. Casanova,et al. Functional STAT3 deficiency compromises the generation of human T follicular helper cells. , 2012, Blood.
[44] A. Fischer,et al. Frequent and Widespread Vascular Abnormalities in Human Signal Transducer and Activator of Transcription 3 Deficiency , 2012, Circulation. Cardiovascular genetics.
[45] S. Holland,et al. A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. , 2011, Immunity.
[46] Sven Kreiborg,et al. Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth. , 2011, American journal of human genetics.
[47] Sami Al-Hajjar,et al. B cell–intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans , 2010, The Journal of experimental medicine.
[48] J. Casanova,et al. A partial form of recessive STAT1 deficiency in humans. , 2009, The Journal of clinical investigation.
[49] H. Takada,et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome , 2007, Nature.
[50] J. Casanova,et al. Novel STAT1 Alleles in Otherwise Healthy Patients with Mycobacterial Disease , 2006, PLoS genetics.
[51] A. Munnich,et al. Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome. , 2004, American journal of human genetics.
[52] Sami Al-Hajjar,et al. Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency , 2003, Nature Genetics.
[53] J. Miyazaki,et al. Tissue-Specific Autoregulation of thestat3 Gene and Its Role in Interleukin-6-Induced Survival Signals in T Cells , 2001, Molecular and Cellular Biology.
[54] Steven M. Holland,et al. Impairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 Mutation , 2001, Science.
[55] T. Hirano,et al. Autoregulation of the Stat3 Gene through Cooperation with a cAMP-responsive Element-binding Protein* , 1998, The Journal of Biological Chemistry.
[56] R. Buckley,et al. EXTREME HYPERIMMUNOGLOBULINEMIA E AND UNDUE SUSCEPTIBILITY TO INFECTION , 1972, Pediatrics.
[57] J. Schaller,et al. Job's Syndrome. Recurrent, "cold", staphylococcal abscesses. , 1966 .